Screener
Neurocrine Biosciences NBIX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Neurocrine Biosciences’s reported figures.
Based on trailing twelve months.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
FAQ
- What is Neurocrine Biosciences's operating margin?
- Neurocrine Biosciences (NBIX) reported operating margin of 25.4% in Q1 2026.
- How has Neurocrine Biosciences's operating margin changed year-over-year?
- Neurocrine Biosciences's operating margin increased by 24.0% year-over-year, from 20.5% to 25.4%.
- What is the long-term trend for Neurocrine Biosciences's operating margin?
- Over 4 years (2020 to 2025), Neurocrine Biosciences's operating margin has grown at a 8.6% compound annual growth rate (CAGR), from 15.6% to 21.6%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Neurocrine Biosciences's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude